Leprosy Mailing List – March 31, 2023
Ref.: (LML) Are we against reducing the risk of painful ENL neuritis?
From: Laila de Laguiche, Curitiba, Brazil
Dear Pieter,
A reply to Joel Almeida's March 26 post
Thanks again to Joel Almeida for taking the time to translate scientifically, in a very didactic way for visualization and with bibliographical references.
In Brazil, mainly in hyperendemic areas, we observed exactly this profile of ENL and neurites.
Brazilian guidelines still insist on maintaining 12 doses of MDT, even with all this scientific evidence.
In fact, we can observe in the clinical evolutions that there are different multibacillary patients and prognoses.
Perhaps we are making a mistake in putting all these patients in the same basket?
Best Regards,
Laila de Laguiche
Curitiba - Brazil
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << editorlml@gmail.com
--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/b0ff5cda-cd60-4861-a734-98d9724b4bean%40googlegroups.com.
No comments:
Post a Comment